Navigation Links
Australia's Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elekta's Advanced 4D Motion Management Technology

SYDNEY, Oct. 31, 2011 /PRNewswire/ -- To successfully irradiate a moving lung tumor requires doctors to find a way either to stop the tumor from moving or a means to compensate for its motion. On September 8, clinicians at Prince of Wales Hospital Cancer Centre (Randwick, New South Wales) chose the second option, using Elekta's Symmetry™ respiratory motion management software for the first time to treat a 75-year-old male patient with a tumor that moved back and forth with his breathing. Symmetry enables physicians to visualize the tumor's complete range of motion and then ensures that the tumor is always positioned in the treatment beam regardless of its movement.

Accurate treatment of this patient's tumor, a primary, malignant non-small cell cancer (NSCLC) in the upper lobe of the left lung, was critical due to the therapy approach used. Prince of Wales Hospital clinicians used hypofractionated Stereotactic Body Radiation Therapy (SBRT), which called for precise immobilization of the patient's body to enable just three treatment sessions (i.e., fractions), each using a highly potent radiation dose.

"The whole concept of hypofractionated stereotactic treatment relies on accurate and precise planning datasets and treatment verification systems," says Wenchang Wong, M.D., radiation oncologist at Prince of Wales Hospital. "Symmetry afforded us clear visualization of the tumor at the treatment couch and gave me confidence that treatment delivery would be safe and reproducible for this patient."

Symmetry, a feature set of Elekta's X-ray Volume Imaging (XVI) software package, enables clear visualization of moving lung tumors by providing a dynamic fourth dimension (4D) of motion to enhance image guidance with the patient in the treatment position.

"Conventional cone beam CT provides only a static, blurred image of a moving lung tumor that cannot tell us in which part of the respiratory cycle it was captured," Dr. Wong explains. "Conversely, Symmetry provides a dynamic 4D cine/picture of the movement of the tumor mass throughout the entire respiratory cycle. This is especially important in lung cancer treatment given the natural excursion of the tumor with the breathing cycle. Symmetry enables us to see the tumor's movement in real time."

Symmetry: From planning to treatment

Hypofractionated SBRT of lung tumors at Prince of Wales involves several Elekta solutions, encompassing planning through to treatment.

To ensure a consistent patient breathing pattern during treatment, planning CT scans are performed with Active Breathing Coordinator™. This Elekta technology enables acquisition of a breathing trace that shows peak inhalation and exhalation points during normal breathing.

"Patients are instructed to hold their breath for 12 seconds at both peak points so that CT scans can be acquired," says Simon Downes, Director of Medical Physics. "The images show the tumor's position at both maximum inhalation and maximum exhalation, and guide treatment planning."

Clinicians plan lung treatments with XiO® treatment planning system. MOSAIQ® Oncology Information System is used to verify and record the plan. For immobilization, Prince of Wales clinicians use BodyFIX®, and Symmetry provides the needed data on tumor position – with Symmetry CBCT scans acquired just before treatment. Patients are treated on the center's Elekta Axesse™ system.

"All of these different systems come together seamlessly to allow us to perform these lung treatments," Downes observes. "In particular, it's remarkable how well Symmetry maps the tumor's position. In a second Symmetry CBCT scan after treatment, we found that we had achieved less than a two millimeter positional error, meaning that the clinical target volume was still enclosed in the treatment field for the entire therapy session. It was a great result."

As lung cancer represents about nine percent of New South Wales' cancer cases, Prince of Wales clinicians anticipate a rapid increase in the number of cases for which Symmetry is employed, he says.

*Approval of indications may vary between different countries.  Additional regulatory clearances may be required in some markets

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website:


Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Single Port Surgeries Now Performed at University Medical Center at Princeton
2. First ShelterBoxes Arrive in Port au Prince - Pictures and Footage
3. Groundbreaking Ceremony in Port-au-Prince, Haiti for FilterPure Water Filtration Factory
4. Pamela Prince-Eason Named Chair Of Board Of Directors For Womens Business Enterprise National Council
5. First Live Web Chat by New Jerseys Princeton HealthCare System Focuses on Womens Health
6. Proventix Helps Princeton Baptist Medical Center Earn National Recognition from HIMSS/ASQ for Quality Improvement Using Information Technology
7. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
8. Gilbert Hospital Continues Cutting Edge Treatments
9. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
10. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
11. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
Post Your Comments:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):